Lack of licensing revenue puts Transmeta back in the red

  • Transmeta exceeded its previously provided guidance for its second quarter with revenues of $9.3 million and a net loss of about $8.5 million. Both numbers are sharp decreases from Q2 of 2005 when the company was able to report $24.7 million and a profit of $6.8 million as a result of licensing its Long Run 2 technology.

    However, Transmeta's future looks much better than a few quarters ago. The company continues to reduce its negative operating cash flow, which came in at a (negative) $7.9 million for the first half of the year.

    The company also expanded its business into new territories such as Microsoft's "FlexGo" that aims affordable PCs at emerging markets. Transmeta announced a cooperation with AMD, which will revive Transmeta's Efficeon processor. AMD will build and market a FlexGo-enabled Efficeon under its own brand in emerging markets, Transmeta said.

Related Stories

Conveying Your Unique Selling Proposition in Ecommerce

How to Get the Perfect Gaming Computer

Can The Iris Network’s Blockchain Tech Save Healthcare?